{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:16:50Z","timestamp":1790543810702,"version":"4.1.0"},"reference-count":30,"publisher":"Pensoft Publishers","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,1]]},"DOI":"10.2478\/v10153-011-0053-2","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T22:11:10Z","timestamp":1324505470000},"source":"Crossref","is-referenced-by-count":2,"title":["Adherence to Bisphosphonate Therapy in Postmenopausal Osteoporotic Women"],"prefix":"10.3897","volume":"53","author":[{"given":"Stefka","family":"Kuzmanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayot","family":"Solakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela","family":"Geneva-Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2258","reference":[{"issue":"1","key":"1","first-page":"1","article-title":"Compliance with osteoporosis medication: challenges for healthcare providers","volume":"10","author":"D. Gold","year":"2005","journal-title":"Medscape Ob\/Gyn & Women's Health"},{"issue":"4","key":"2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","article-title":"Comparison of drug adherence rates among patients with seven different medical conditions","volume":"28","author":"B. Briesacher","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"12","key":"3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.4065\/82.12.1493","article-title":"Systemic review and meta-analysis of real-world adherence to drug therapy for osteoporosis","volume":"82","author":"P. Kothawala","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"4","unstructured":"Kanis JA, McCloskey EV, Johansson H. Approaches to the targeting of treatment for osteoporosis. CME released 08\/03\/2009 <a target=\"_blank\" href='http:\/\/cme.medscape.com\/viewarticle\/706368'>http:\/\/cme.medscape.com\/viewarticle\/706368<\/a>"},{"issue":"4","key":"5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/BOR.0b013e328172dc1a","article-title":"New and emerging treatment for osteoporosis","volume":"19","author":"M. Maricis","year":"2007","journal-title":"Cur Opin Rheumatol"},{"key":"6","unstructured":"Mabotuwana T, Warren J, Gaikwad R. University Aukland 1142, New Zealand 2009, Private bag 92019."},{"issue":"2","key":"7","first-page":"47","article-title":"Adherence to medications for the treatment of osteoporosis","volume":"3","author":"S. Silverman","year":"2008","journal-title":"US musculoskeletal review"},{"issue":"12","key":"8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1185\/030079906X154079","article-title":"European women's preference for osteoporosis treatment: influence of clinical effectiveness and dosing frequency","volume":"22","author":"R. Keen","year":"2006","journal-title":"Cur Med Research Opinions"},{"issue":"6","key":"9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1345\/aph.1G534","article-title":"How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosponate therapy","volume":"40","author":"D. Gold","year":"2006","journal-title":"Ann Pharmacotherapy"},{"issue":"5","key":"10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00198-005-0031-8","article-title":"Does an educational leaflet improve self-adherence to therapy in osteoporosis?","volume":"17","author":"M. Guilera","year":"2006","journal-title":"Osteoporosis Int"},{"issue":"1","key":"11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","article-title":"Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases","volume":"81","author":"E. Siris","year":"2006","journal-title":"Mayo Clinic Proceedings"},{"issue":"3","key":"12","first-page":"8811","article-title":"Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women","volume":"19","author":"V. Rabenda","year":"2008","journal-title":"Osteoporosis Int"},{"issue":"11","key":"13","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00198-008-0716-x","article-title":"Osteoporosis care at risk in United States","volume":"19","author":"E. Lewiecki","year":"2008","journal-title":"Osteoporosis Int"},{"issue":"1","key":"14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-008-0644-9","article-title":"Incorporating adherence into health economic modeling of osteoporosis","volume":"20","author":"O. Str\u00f6m","year":"2009","journal-title":"Osteoporosis Int"},{"issue":"9","key":"15","first-page":"404","article-title":"Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline","volume":"149","author":"A. Oaseem","year":"2008","journal-title":"Ann Intern Med"},{"issue":"6","key":"16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1345\/aph.1G534","article-title":"Haw can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy","volume":"40","author":"D. Gold","year":"2006","journal-title":"Ann Pharmacotherapy"},{"issue":"8","key":"17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4065\/81.8.1009","article-title":"A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence and adherence","volume":"81","author":"E. Badamagarav","year":"2006","journal-title":"Mayo Clin Proceedings"},{"issue":"10","key":"18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00198-007-0410-4","article-title":"Adherence to treatment of osteoporosis: a need for study","volume":"18","author":"F. Lekkerkerker","year":"2007","journal-title":"Osteoporosis Int"},{"issue":"3","key":"19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jc.2006-1856","article-title":"Discontinuation of antiresorptive therapies: a comparison between 1998-2001 and 2002-2004 among osteoporotic women","volume":"92","author":"J. Blouin","year":"2007","journal-title":"J Clin Endocrinology & Metbol"},{"issue":"1","key":"20","article-title":"Adherence and causes for nonpersistence in patients treated for osteoporosis","volume":"22","author":"B. Dogu","year":"2011","journal-title":"Osteoporosis Int"},{"key":"21","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00198-010-1223-4","article-title":"Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club","volume":"21","author":"J. Body","year":"2010","journal-title":"Osteoporosis Int"},{"issue":"10","key":"22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-008-0661-8","article-title":"Assessing response to osteoporosis therapy","volume":"19","author":"E. Lewiecki","year":"2008","journal-title":"Osteoporosis Int"},{"issue":"20","key":"23","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/archinte.165.20.2414","article-title":"Compliance with osteoporosis medication","volume":"165","author":"D. Solomon","year":"2005","journal-title":"Ann Intern Med"},{"issue":"4","key":"24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-150-4-200902170-00024","article-title":"Is too much intervention recommended in ACR osteoporosis treatment guidelines?","volume":"150","author":"P. Coello","year":"2009","journal-title":"Ann Intern Med"},{"key":"25","article-title":"A new, better therapy for osteoporosis?","author":"K. Deane","year":"2009","journal-title":"Medscape Rheumatology"},{"key":"26","author":"P. Solakov","year":"2009"},{"issue":"1","key":"27","first-page":"84","article-title":"Postmenopausal osteoporosis prevalence in a South Bulgarian city","volume":"17","author":"P. Solakov","year":"2006","journal-title":"Osteoporosis Int"},{"key":"28","unstructured":"World Health Organization. Assessment of osteoporosis at the primary health care. Report of a WHO scientific group (online) <a target=\"_blank\" href='http:\/\/www.who.int\/chp\/topics\/heumatic\/enindex.html'>www.who.int\/chp\/topics\/heumatic\/enindex.html<\/a>"},{"key":"29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2009.03.387","article-title":"Adherence to osteoporosis therapy in real life setting with a long follow-up","volume":"44","author":"A. Giardina","year":"2009","journal-title":"Bone"},{"issue":"12","key":"30","first-page":"2063","article-title":"Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta analysis","volume":"20","author":"I. Imaz","year":"2009","journal-title":"Osteoporosis Int"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/view\/j\/folmed.2011.53.issue-3\/v10153-011-0053-2\/v10153-011-0053-2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T18:35:50Z","timestamp":1565807750000},"score":1,"resource":{"primary":{"URL":"http:\/\/content.sciendo.com\/view\/journals\/folmed\/53\/3\/article-p25.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,1]]},"references-count":30,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.2478\/v10153-011-0053-2","relation":{},"ISSN":["1314-2143","0204-8043"],"issn-type":[{"value":"1314-2143","type":"electronic"},{"value":"0204-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,1]]}}}